Prevalence of a Novel Immunogenic Feline Erythrocyte Antigen (FEA 6) and Expression Patterns Between FEAs
Journal of Veterinary Internal Medicine · 2025
DOI: 10.1111/jvim.70094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von Félix Bajon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre Hospitalier Universitaire Vétérinaire, Faculté de médecine vétérinaire, University of Montreal, Saint-Hyacinthe, Canada. Hauptthemen laut MEDLINE: Erythrocytes, Blood Group Antigens. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Background
After the identification of five novel feline erythrocyte antigens (FEAs) and evidence establishing FEA 1's immunogenicity, attempts to sensitize a cat to FEA 4 unexpectedly resulted in the production of alloantibodies directed against an unknown antigen, named FEA 6.
Objectives
To estimate the prevalence of FEA 6 as a presumably new antigen, identify corresponding naturally occurring alloantibodies (NOAb), and investigate the associations between known FEAs. Animals Two hundread and seven cats.
Methods
Prospective blood typing for FEAs 1–6 was conducted in Type A cats (n = 193), followed by serial crossmatching in groups of 3–7 cats to detect NOAb and identify their target FEA. Agreement between FEA 6 blood typing and other FEAs was assessed. Associations between FEAs were evaluated to identify expression patterns.
Results
Among 193 Type A cats, 67% were FEA 6-positive. Agreement analyses were supportive of FEA 6 being distinct from FEAs 1–5. NOAb were detected in 11 cats (5.7%), none of which were anti-FEA 6. Only FEA 1-negative status was significantly associated with the presence of NOAb (OR = 6.6, 95% CI, 1.9–23.1; p < 0.001). Significant associations were observed between the expressions of FEAs 1 and 4 (χ2 = 25.7, p < 0.001), and FEAs 3 and 5 (Fisher's exact test, p < 0.001), respectively. Conclusions and Clinical Importance The immunogenicity and prevalence of the newly discovered FEA 6 raise concerns regarding its clinical relevance and role in posttransfusion sensitization. FEA 1/FEA 4 and FEA 3/FEA 5 pairs might belong to distinct antigenic systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre Hospitalier Universitaire Vétérinaire, Faculté de médecine vétérinaire, University of Montreal, Saint-Hyacinthe, Canada.
- Department of Pathology and Microbiology, Faculté de médecine vétérinaire, University of Montreal, Saint-Hyacinthe, Canada.
- Department of Clinical Sciences, Faculté de médecine vétérinaire, University of Montreal, Saint-Hyacinthe, Canada.
ORCID-Profile: Félix Bajon, Julie Arsenault
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Bajon, F., Arsenault, J., & Blais, M. C. (2025). Prevalence of a Novel Immunogenic Feline Erythrocyte Antigen (FEA 6) and Expression Patterns Between FEAs. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70094
Vancouver
Bajon F, Arsenault J, Blais MC. Prevalence of a Novel Immunogenic Feline Erythrocyte Antigen (FEA 6) and Expression Patterns Between FEAs. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70094
BibTeX
@article{Bajon2025,
author = {Bajon, Félix and Arsenault, Julie and Blais, Marie Claude},
title = {Prevalence of a Novel Immunogenic Feline Erythrocyte Antigen (FEA 6) and Expression Patterns Between FEAs},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
doi = {10.1111/jvim.70094}
}
EUVIMED